Perspective Therapeutics (CATX) Balance Sheet: Assets & Liabilities

Perspective Therapeutics (CATX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Perspective Therapeutics reported total assets of $266.97M and total liabilities of $59.94M. Shareholders' equity was $207.03M, down 28.8% from $290.67M a year earlier. Total debt stood at $1.63M against $144.74M in cash and short-term investments, a net cash position of $143.11M. That puts debt-to-equity at 0.01, compared with 0.01 a year earlier.

Perspective Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Perspective Therapeutics, Inc. (CATX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018
Current Assets
Cash and Cash Equivalents	30.63	61.58	9.24	20.99	63.83	9.59	2.39	5.33
Short-Term Investments	114.11	165.34	0.00	22.76	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	144.74	226.92	9.24	43.76	63.83	9.59	2.39	5.33
Accounts Receivable	0.01	0.12	1.17	1.36	2.01	1.74	2.04	1.15
Inventory	0.00	0.00	0.00	1.40	0.98	0.67	0.65	0.53
Other Current Assets	3.65	4.13	0.05	6.70	0.03	0.30	0.43	0.31
Total Current Assets	148.39	231.16	16.84	53.22	67.30	12.29	5.51	7.32
Non-Current Assets
Property, Plant & Equipment (Net)	78.10	59.54	6.32	0.37	2.73	2.72	2.74	1.61
Long-Term Investments	0.28	0.13	0.13	0.15	0.00	0.00	0.18	0.18
Goodwill	0.00	0.00	24.06	0.00	0.00	0.00	0.00	0.00
Intangible Assets	40.00	50.01	50.35	0.03	0.13	0.13	0.14	0.16
Other Non-Current Assets	0.49	0.41	0.18	4.33	0.26	0.37	0.14	0.16
Total Non-Current Assets	118.58	109.94	81.05	4.88	3.11	3.22	3.19	2.11
Total Assets	266.97	341.10	97.89	58.09	70.42	15.51	8.70	9.42
Current Liabilities
Accounts Payable	20.51	10.34	6.91	1.54	0.73	0.49	0.65	0.68
Short-Term Debt	0.06	0.05	0.05	0.27	0.27	0.25	0.24	0.00
Current Portion of Long-Term Debt	0.06	0.05	0.05	-	-	-	-	-
Accrued Liabilities	7.49	5.48	3.93	0.78	0.56	-	-	-
Deferred Revenue	0.00	1.40	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	7.49	0.50	5.07	1.31	1.03	0.39	0.33	0.35
Total Current Liabilities	28.68	18.23	15.66	3.12	1.80	1.34	1.58	1.12
Non-Current Liabilities
Long-Term Debt	1.57	1.63	1.68	0.26	0.52	0.65	0.77	0.00
Deferred Tax Liabilities	1.70	2.50	4.59	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	28.69	29.15	4.59	0.08	0.69	0.75	0.63	0.62
Total Non-Current Liabilities	31.26	32.20	7.05	0.33	1.21	1.41	1.40	0.62
Total Liabilities	59.94	50.43	22.71	3.45	3.01	2.74	2.98	1.74
Stockholders' Equity
Common Stock	0.07	0.07	0.03	0.14	0.14	0.09	0.07	0.07
Retained Earnings	-334.84	-231.72	-152.44	-105.93	-91.33	-89.52	-87.94	-84.49
Accumulated Other Comprehensive Income	0.11	-0.05	0.00	0.00	0.00	0.00	0.00	0.00
Additional Paid-in Capital	541.69	522.37	227.59	160.43	158.59	102.21	93.59	92.11
Shares Outstanding	74.34	70.67	28.18	14.20	14.19	-	-	-
Total Stockholders' Equity	207.03	290.67	75.18	54.64	67.41	12.77	5.72	7.68
Total Liabilities & Equity	266.97	341.10	97.89	58.09	70.42	15.51	8.70	9.42

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Perspective Therapeutics Balance Sheet

How much debt does Perspective Therapeutics have?

Perspective Therapeutics had total debt of $1.63M as of Dec 31, 2025, against $144.74M in cash and short-term investments. Its debt-to-equity ratio was 0.01. Total debt was $1.68M a year earlier.

What are Perspective Therapeutics's total assets?

Perspective Therapeutics reported total assets of $266.97M as of Dec 31, 2025, down 21.7% from $341.10M a year earlier. Total liabilities were $59.94M.

What is Perspective Therapeutics's shareholders' equity?

Perspective Therapeutics's shareholders' equity was $207.03M as of Dec 31, 2025, or about $2.78 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition